Rett syndrome is a neurodevelopmental disease without evidence of degeneration and thus rescuing MECP2 downstream activity might improve disease pathophysiology even in adulthood (Faundez et al., 2019). The gene discussed is MECP2; the disease is atypical Rett syndrome.